Any feedback?
Literature summary for 3.4.14.5 extracted from
- Sitagliptin: profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update) (2007), Drugs Today, 43, 801-814.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the DPP-4 inhibitor sitagliptin is effective in treatment of type 2 diabetes. Overview of the mechanisms of action, pharmacology and clinical trial results of sitagliptin. DPP-4 inhibitors could be used in prediabetic stages and the very early stages of diabetes to slow or prevent the progression of type 2 diabetes | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| sitagliptin | - |
Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| DPP-4 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
